E I Du Pont De Nemours And Co  

(Public, NYSE:DD)   Watch this stock  
Find more results for DD
84.54
-0.29 (-0.34%)
Jul 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 84.25 - 85.04
52 week 66.02 - 85.48
Open 84.83
Vol / Avg. 0.00/2.12M
Mkt cap 73.05B
P/E 28.33
Div/yield 0.38/1.80
EPS 2.98
Shares 867.03M
Beta 1.76
Inst. own 72%
Jul 25, 2017
Q2 2017 E I du Pont de Nemours and Co Earnings Release - 9:30AM EDT - Add to calendar
Jul 25, 2017
Q2 2017 E I du Pont de Nemours and Co Earnings Call - 8:00AM EDT - Add to calendar
May 24, 2017
E I du Pont de Nemours and Co Annual Shareholders Meeting
Apr 25, 2017
Q1 2017 E I du Pont de Nemours and Co Earnings Release
Apr 25, 2017
Q1 2017 E I du Pont de Nemours and Co Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 17.28% 10.25%
Operating margin 17.73% 12.71%
EBITD margin - 20.07%
Return on average assets 13.12% 6.21%
Return on average equity 50.84% 25.61%
Employees 46,000 -
CDP Score - A-

Address

974 Centre Rd
WILMINGTON, DE 19805-1269
United States - Map
+1-302-7741000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

E. I. du Pont de Nemours and Company is a science and technology-based company. It operates through six segments: Agriculture, Electronics & Communications (E&C), Industrial Biosciences, Nutrition & Health, Performance Materials and Protection Solutions. Its Agriculture segment includes products, such as corn hybrids and soybean varieties, herbicides, fungicides and insecticides. Its E&C segment includes products, such as printing and packaging materials, photopolymers and electronic materials. Its Industrial Biosciences segment includes products, such as enzymes, bio-based materials and process technologies. Its Nutrition & Health segment includes products, such as probiotics, cultures, emulsifiers, natural sweeteners and soy-based food ingredients. Its Performance Materials segment includes products, such as engineering polymers, packaging and industrial polymers, films and elastomers. Its Protection Solutions segment includes products, such as nonwovens, aramids and solid surfaces.

Officers and directors

Edward D. Breen Chairman of the Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Nicholas Charles Fanandakis Chief Financial Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
James C. Collins Jr. Executive Vice President
Age: 54
Bio & Compensation  - Reuters
C. Marc Doyle Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Stacy L. Fox Senior Vice President, General Counsel
Age: 63
Bio & Compensation  - Reuters
Benito Cachinero-Sanchez Senior Vice President - Human Resources
Age: 58
Bio & Compensation  - Reuters
Douglas W. Muzyka Senior Vice President and Chief Science & Technology Officer
Age: 62
Bio & Compensation  - Reuters
Lamberto Andreotti Independent Director
Age: 66
Bio & Compensation  - Reuters
Robert A. Brown Independent Director
Age: 65
Bio & Compensation  - Reuters
Alexander M. Cutler Independent Director
Age: 65
Bio & Compensation  - Reuters